{"created":"2023-05-15T09:05:28.288504+00:00","id":6758,"links":{},"metadata":{"_buckets":{"deposit":"73256263-764a-4ae7-9bb8-c93ed3205e52"},"_deposit":{"created_by":11,"id":"6758","owners":[11],"pid":{"revision_id":0,"type":"depid","value":"6758"},"status":"published"},"_oai":{"id":"oai:hirosaki.repo.nii.ac.jp:00006758","sets":["557:561:1053"]},"author_link":["20840","20841"],"item_3_alternative_title_21":{"attribute_name":"その他のタイトル","attribute_value_mlt":[{"subitem_alternative_title":"Beneficial effects of combination therapy of canagliflozin and teneligliptin on diabetic polyneuropathy and β-cell volume density in spontaneously type 2 diabetic Goto-Kakizaki rats"}]},"item_3_biblio_info_8":{"attribute_name":"書誌情報","attribute_value_mlt":[{"bibliographicIssueDates":{"bibliographicIssueDate":"2022-03-10","bibliographicIssueDateType":"Issued"},"bibliographicIssueNumber":"1-4","bibliographicPageEnd":"90","bibliographicPageStart":"87","bibliographicVolumeNumber":"72","bibliographic_titles":[{"bibliographic_title":"弘前医学"}]}]},"item_3_full_name_2":{"attribute_name":"著者(ヨミ)","attribute_value_mlt":[{"nameIdentifiers":[{"nameIdentifier":"20841","nameIdentifierScheme":"WEKO"}],"names":[{"name":"グォ, ダンヤン"}]}]},"item_3_publisher_35":{"attribute_name":"出版者","attribute_value_mlt":[{"subitem_publisher":"弘前大学大学院医学研究科"}]},"item_3_radio_42":{"attribute_name":"資源タイプ","attribute_value_mlt":[{"subitem_radio_item":"Article"}]},"item_3_source_id_11":{"attribute_name":"書誌レコードID","attribute_value_mlt":[{"subitem_source_identifier":"AN00211444","subitem_source_identifier_type":"NCID"}]},"item_3_source_id_9":{"attribute_name":"ISSN","attribute_value_mlt":[{"subitem_source_identifier":"0439-1721","subitem_source_identifier_type":"ISSN"}]},"item_3_text_4":{"attribute_name":"著者所属","attribute_value_mlt":[{"subitem_text_value":"中国医科大学附属第一病院　病理学講座, 弘前大学大学院医学研究科　分子病態病理学講座"}]},"item_3_version_type_18":{"attribute_name":"著者版フラグ","attribute_value_mlt":[{"subitem_version_resource":"http://purl.org/coar/version/c_970fb48d4fbd8a85","subitem_version_type":"VoR"}]},"item_creator":{"attribute_name":"著者","attribute_type":"creator","attribute_value_mlt":[{"creatorNames":[{"creatorName":"郭, 丹陽"}],"nameIdentifiers":[{}]}]},"item_files":{"attribute_name":"ファイル情報","attribute_type":"file","attribute_value_mlt":[{"accessrole":"open_access","displaytype":"detail","filename":"Hirosaki Med J 72-1-4_87.pdf","filesize":[{"value":"306.0 kB"}],"format":"application/pdf","licensetype":"license_note","mimetype":"application/pdf","url":{"url":"https://hirosaki.repo.nii.ac.jp/record/6758/files/Hirosaki Med J 72-1-4_87.pdf"},"version_id":"965a520f-b2c3-4301-95c1-e104d09b427b"}]},"item_language":{"attribute_name":"言語","attribute_value_mlt":[{"subitem_language":"jpn"}]},"item_resource_type":{"attribute_name":"資源タイプ","attribute_value_mlt":[{"resourcetype":"journal article","resourceuri":"http://purl.org/coar/resource_type/c_6501"}]},"item_title":"カナグリフロジンとテネリグリプチンの併用療法は自然発症2 型糖尿病モデルGoto-Kakizaki ラットにおける神経障害とβ 細胞容積を改善する","item_titles":{"attribute_name":"タイトル","attribute_value_mlt":[{"subitem_title":"カナグリフロジンとテネリグリプチンの併用療法は自然発症2 型糖尿病モデルGoto-Kakizaki ラットにおける神経障害とβ 細胞容積を改善する"}]},"item_type_id":"3","owner":"11","path":["1053"],"pubdate":{"attribute_name":"公開日","attribute_value":"2022-04-27"},"publish_date":"2022-04-27","publish_status":"0","recid":"6758","relation_version_is_last":true,"title":["カナグリフロジンとテネリグリプチンの併用療法は自然発症2 型糖尿病モデルGoto-Kakizaki ラットにおける神経障害とβ 細胞容積を改善する"],"weko_creator_id":"11","weko_shared_id":-1},"updated":"2023-05-15T11:31:57.804307+00:00"}